Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Declaration of Voting Results & Voting Rights Announcements 2011

May 19, 2011

6990_rns_2011-05-20_819e7157-767a-4dc1-b12e-e82698497b43.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in viewer

Opens in your device viewer

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 19, 2011 (May 17, 2011)

PLURISTEM THERAPEUTICS INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada (State or Other Jurisdiction of Incorporation)

001-31392 (Commission File Number)

98-0351734 (IRS Employer Identification No.)

MATAM Advanced Technology Park Building No. 20 Haifa, Israel (Address of Principal Executive Offices)

31905 (Zip Code)

011 972 74 710 7171 (Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 5.07. Submission of Matters to a Vote of Security Holders.

Pluristem Therapeutics Inc. (the “Company”), held its annual meeting of stockholders on May 17, 2011. Results of stockholder voting at the annual meeting are set forth below.

PROPOSAL NO. 1 — ELECTION OF DIRECTORS.

The stockholders elected the following individuals as Directors of the Company to hold office until the next annual meeting of shareholders and until their successors shall have been duly elected and qualified.

Director Name For Against Abstain Broker Non-Votes
Zami Aberman 12,153,803 1,934,237 83,091 0
Israel Ben-Yoram 13,820,986 17,379 332,766 0
Isaac Braun 13,822,966 15,399 332,766 0
Mark Germain 11,933,374 1,904,991 332,766 0
Hava Meretzki 13,355,179 572,749 243,203 0
Shai Pines 13,884,573 16,999 269,559 0
Nachum Rosman 12,189,990 1,648,415 332,726 0
Doron Shorrer 13,817,847 21,018 332,266 0

The results reported above are final voting results.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

PLURISTEM THERAPEUTICS INC.

Date: May 19, 2011

By: /s/ Yaky Yanay

Name: Yaky Yanay

Title: Chief Financial Officer